The “Global HPV Testing and Pap Test Market By Type, By Application, By Product, By End Use, By Regional Outlook, Industry Analysis Report and Forecast, 2021 – 2027” report has been added to ResearchAndMarkets.com’s offering.
The Global HPV Testing and Pap Test Market size is expected to reach $7.1 billion by 2027, rising at a market growth of 33.5% CAGR during the forecast period.
Pap tests and HPV Testing both are included in cervical cancer screening which is a crucial part of a woman’s routine health checkup as it can discover cancer of abnormalities that could result in cancer of the cervix. It is suggested that a woman should undergo a Pap test every 3 years starting from the age of 21.
Also, it is further recommended that women between the ages of 30 to 65 should undergo Pap and HPV every after 5 years or a Pap test in 3 years. Women having some risk factors may require more often screening or to keep on screening themselves even after the age of 65 years.
Some of the determinants that boost the demand & growth of HPV testing and Pap test are constant technological developments, a rising number of cervical cancer screening programs, and growing cases of cervical cancer. On the other hand, the global COVID-19 crisis and the imposition of various lockdown norms and restrictions to keep people in their homes have substantially decreased routine cancer screenings.
Interruptions in cancer screening services have been observed in a majority of settings as a result of the global coronavirus crisis. Guidelines for cancer screening activities are generally created after systematic and careful consideration of the optimally available evidence to provide high-quality care and to cut down variability in clinical practice.
Though, the beginning of the COVID-19 pandemic needed an instant response at a time when the duration of the pandemic could not be predicted and the nature of the virus was still majorly unidentified. In the majority of settings, the consequence of this situation was a time-restricted deferment of services. These disturbances are anticipated to cause highly advanced cancer diagnoses and deaths in the next few years.
Screening services have now restarted to some extent in most of the countries; though, subsequent the deadly COVID-19 outbreak continues to create disruption in healthcare provisions. In spite of the approval of different secure and extremely effective COVID-19 vaccines, supply constraints have deferred their roll-out. Hence, the present disruptions to health care, in general, are expected to remain the same for some time. Therefore, the outbreak of COVID-19 pandemic has adversely affected the HPV testing and Pap test market.
The market research report covers the analysis of key stakeholders of the market.
Key companies profiled in the report include
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Hologic, Inc.
- Quest Diagnostics, Incorporated
- Seegene, Inc.
- Arbor Vita Corporation
- Femasys, Inc.
- Qiagen N.V.
Key Topics Covered:
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.3 Market Scope
Chapter 2. Market Overview
2.1.2 Market Composition & Scenario:
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
2.2.3 Market Opportunity
Chapter 3. Global HPV Testing And Pap Test Market by Type
3.1 Global Pap Test Market by Region
3.2 Global HPV Testing Market by Region
Chapter 4. Global HPV Testing And Pap Test Market by Application
4.1 Global Cervical Cancer Screening Market by Region
4.2 Global Vaginal Cancer Screening Market by Region
Chapter 5. Global HPV Testing And Pap Test Market by Product
5.1 Global Consumables Market by Region
5.2 Global Instruments Market by Region
5.3 Global Services Market by Region
Chapter 6. Global HPV Testing And Pap Test Market by Technology
6.1 Global PCR Market by Region
6.2 Global Immunodiagnostics Market by Region
6.3 Global Other Technologies Market by Region
Chapter 7. Global HPV Testing And Pap Test Market by End Use
7.1 Global Hospitals & Clinics Market by Region
7.2 Global Laboratories Market by Region
7.3 Global Other End Use Market by Region
Chapter 8. Global HPV Testing And Pap Test Market by Region
Chapter 9. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/jjkq7r
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900